Patient #3 also exhibited reemergence of tremor intensity concomitant with a decreasing trend in sweat L-DOPA concentration, indicating the possibility of L-DOPA wearing-off.
← all excerpts
Wearable sensors for monitoring drug pharmacokinetics in patients with Parkinson's disease.
1
—
—